Loading…
Attending this event?
Back To Schedule
Tuesday, June 21 • 4:15pm - 5:15pm
#267: Improving Safety Data Through Innovative Use of Technology

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Component Type: Forum
Level: Intermediate
CE: ACPE 1.00 Application UAN: 0286-0000-22-580-L04-P ; CME 1.00; RN 1.00

The speakers will aim to share their experience as a case study on how multitenant hosted solutions in PV: enable a standardized approach for Adverse Event and Signal Management processes for all products and compounds across all markets globally, leverage automation and other innovative capabilities that deliver efficiencies in case processing, and encourage a philosophy of using industry standard practices to align and improve overall process, based on input from multiple pharma companies and health authorities, ultimately influencing them rolling forward.

Learning Objectives

Discuss current-state applications of artificial intelligence (AI) and cloud applications in pharmacovigilance; Describe current and future opportunities and limitations of the use of AI and toxicogenomics in patient safety; Assess the changing regulatory environment.

Chair

Sameen Desai, MBA, MS

Speaker

Moderator
Jeremy Jokinen, PhD, MS

Safety Lessons for Pharmaceuticals from Other Industries
Alan M Hochberg

FDA Update
Keith K. Burkhart, MD

Industry Update
Seth Krevat, MD, FACP

Cloud-Based System for Pharmacovigilance: A Case Study
Eileen Leonard, PharmD



Speakers
KB

Keith Burkhart

Senior Advisor for Medical Toxicology, DARS, OCP, OTS, FDA, United States
Dr. Burkhart received his medical toxicology training at the Rocky Mountain Poison Center in Denver. He received his Emergency Medicine training at the University of Cincinnati. He is the former Medical Director of the Penn State Poison Center. Clinical care has been provided at the... Read More →
avatar for Sameen Desai

Sameen Desai

Executive Director, IT Worldwide Patient Safety, Bristol-Myers Squibb Company, United States
avatar for Alan Hochberg

Alan Hochberg

Principal Scientific Enablement Director, F. Hoffmann-La Roche, Switzerland
Alan Hochberg is a Scientific Enablement Leader at Roche in Basel, involved in bringing innovations into the pharmacovigilance system. He was formerly with ProSanos, where he developed and evaluated signal-detection algorithms. He has worked in bioinformatics and biomedical engineering... Read More →
avatar for Jeremy Jokinen

Jeremy Jokinen

Vice President and Head, Global Risk Management & International Patient Safety, Bristol Myers Squibb Company, United States
Jeremy is the Vice President and Head, Global Risk Management and International Patient Safety at Bristol Myers Squibb. In this role, he leads a global team of risk management and safety science leaders responsible for insights, evidence generation, and risk minimization efforts ensuring... Read More →
SK

Seth Krevat

Senior Medical Director and Assistant Vice President, Medstar Health, United States
Dr. Krevat practices palliative care at MedStar Georgetown University Hospital, is the senior medical director at MedStar Health National Center for Human Factors in Healthcare and is an assistant professor of clinical medicine at Georgetown University School of Medicine. Dr. Krevat... Read More →
EL

Eileen Leonard

Vice President, Worldwide Patient Safety, Bristol-Myers Squibb Company, United States
Eileen is Vice President of Global Safety Operations in Worldwide Patient Safety at Bristol-Myers Squibb. Prior to joining BMS in 2007, Eileen spent over nine years in the CRO industry managing outsourced safety services and over 12 years in clinical practice in both academic and... Read More →


Tuesday June 21, 2022 4:15pm - 5:15pm CDT
Room 175 McCormick Place 2301 South Indiana Avenue Gate 40 Chicago, IL 60616
  01: ClinSafety-PV, Forum